66 related articles for article (PubMed ID: 24654752)
1. Evidence for circulating cancer stem-like cells and epithelial-mesenchymal transition phenotype in the pleurospheres derived from lung adenocarcinoma using liquid biopsy.
Mirza S; Jain N; Rawal R
Tumour Biol; 2017 Mar; 39(3):1010428317695915. PubMed ID: 28347243
[TBL] [Abstract][Full Text] [Related]
2. Hybrid upconversion nanomaterials for optogenetic neuronal control.
Shah S; Liu JJ; Pasquale N; Lai J; McGowan H; Pang ZP; Lee KB
Nanoscale; 2015 Oct; 7(40):16571-7. PubMed ID: 26415758
[TBL] [Abstract][Full Text] [Related]
3. Reduced graphene oxide-coated hydroxyapatite composites stimulate spontaneous osteogenic differentiation of human mesenchymal stem cells.
Lee JH; Shin YC; Jin OS; Kang SH; Hwang YS; Park JC; Hong SW; Han DW
Nanoscale; 2015 Jul; 7(27):11642-51. PubMed ID: 26098486
[TBL] [Abstract][Full Text] [Related]
4. Structural Insights into the Human Pre-mRNA 3'-End Processing Machinery.
Zhang Y; Sun Y; Shi Y; Walz T; Tong L
Mol Cell; 2020 Feb; 77(4):800-809.e6. PubMed ID: 31810758
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of TWA1 predicts poor prognosis in patients with gastric cancer.
Xiong J; Feng Z; Li Z; Zhong T; Yang Z; Tu Y; Xiao T; Jie Z; Cao Y
Pathol Res Pract; 2019 Nov; 215(11):152594. PubMed ID: 31591053
[TBL] [Abstract][Full Text] [Related]
6. Identification of the hub genes related to adipose tissue metabolism of bovine.
Wang X; Wang J; Raza SHA; Deng J; Ma J; Qu X; Yu S; Zhang D; Alshammari AM; Almohaimeed HM; Zan L
Front Vet Sci; 2022; 9():1014286. PubMed ID: 36439361
[TBL] [Abstract][Full Text] [Related]
7. Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke.
Hiwasa T; Wang H; Goto KI; Mine S; Machida T; Kobayashi E; Yoshida Y; Adachi A; Matsutani T; Sata M; Yamagishi K; Iso H; Sawada N; Tsugane S; Kunimatsu M; Kamitsukasa I; Mori M; Sugimoto K; Uzawa A; Muto M; Kuwabara S; Kobayashi Y; Ohno M; Nishi E; Hattori A; Yamamoto M; Maezawa Y; Kobayashi K; Ishibashi R; Takemoto M; Yokote K; Takizawa H; Kishimoto T; Matsushita K; Kobayashi S; Nomura F; Arasawa T; Kagaya A; Maruyama T; Matsubara H; Tomiita M; Hamanaka S; Imai Y; Nakagawa T; Kato N; Terada J; Matsumura T; Katsumata Y; Naito A; Tanabe N; Sakao S; Tatsumi K; Ito M; Shiratori F; Sumazaki M; Yajima S; Shimada H; Shirouzu M; Yokoyama S; Kudo T; Doi H; Iwase K; Ashino H; Li SY; Kubota M; Tomiyoshi G; Shinmen N; Nakamura R; Kuroda H; Iwadate Y
BMC Med; 2021 Jun; 19(1):131. PubMed ID: 34103026
[TBL] [Abstract][Full Text] [Related]
8. Total thyroidectomy versus lobectomy: surgical approach to T1-T2 papillary thyroid cancer.
Di Filippo L; Giugliano G; Tagliabue M; Gandini S; Sileo F; Allora A; Grosso E; Proh M; Basso V; Scaglione D; Manzoni MF; Ansarin M
Acta Otorhinolaryngol Ital; 2020 Aug; 40(4):254-261. PubMed ID: 33100336
[TBL] [Abstract][Full Text] [Related]
9. CPSF3 is a promising prognostic biomarker and predicts recurrence of non-small cell lung cancer.
Ning Y; Liu W; Guan X; Xie X; Zhang Y
Oncol Lett; 2019 Sep; 18(3):2835-2844. PubMed ID: 31452762
[TBL] [Abstract][Full Text] [Related]
10. Trop2 enhances invasion of thyroid cancer by inducing MMP2 through ERK and JNK pathways.
Guan H; Guo Z; Liang W; Li H; Wei G; Xu L; Xiao H; Li Y
BMC Cancer; 2017 Jul; 17(1):486. PubMed ID: 28709407
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells.
Song HM; Luo Y; Li DF; Wei CK; Hua KY; Song JL; Xu H; Maskey N; Fang L
Int J Clin Exp Pathol; 2015; 8(9):9889-900. PubMed ID: 26617698
[TBL] [Abstract][Full Text] [Related]
12. Current status and future perspectives in differentiated thyroid cancer.
Kim TY; Kim WG; Kim WB; Shong YK
Endocrinol Metab (Seoul); 2014 Sep; 29(3):217-25. PubMed ID: 25309778
[TBL] [Abstract][Full Text] [Related]
13. Loss of CPSF2 expression is associated with increased thyroid cancer cellular invasion and cancer stem cell population, and more aggressive disease.
Nilubol N; Boufraqech M; Zhang L; Kebebew E
J Clin Endocrinol Metab; 2014 Jul; 99(7):E1173-82. PubMed ID: 24654752
[TBL] [Abstract][Full Text] [Related]
14. Negative Expression of CPSF2 Predicts a Poorer Clinical Outcome in Patients with Papillary Thyroid Carcinoma.
Sung TY; Kim M; Kim TY; Kim WG; Park Y; Song DE; Park SY; Kwon H; Choi YM; Jang EK; Jeon MJ; Shong YK; Hong SJ; Kim WB
Thyroid; 2015 Sep; 25(9):1020-5. PubMed ID: 26148673
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Significance of BRAF V600E Mutation and CPSF2 Protein Expression in Papillary Thyroid Cancer.
Ivković I; Limani Z; Jakovčević A; Gajović S; Seiwerth S; Đanić Hadžibegović A; Prgomet D
Biomedicines; 2022 Dec; 11(1):. PubMed ID: 36672561
[TBL] [Abstract][Full Text] [Related]
16. Epigenetically upregulated WIPF1 plays a major role in BRAF V600E-promoted papillary thyroid cancer aggressiveness.
Zhang T; Shen X; Liu R; Zhu G; Bishop J; Xing M
Oncotarget; 2017 Jan; 8(1):900-914. PubMed ID: 27863429
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-146b: A Novel Biomarker and Therapeutic Target for Human Papillary Thyroid Cancer.
Chou CK; Liu RT; Kang HY
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28294980
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
